The individual effect of the ADRB2 genotype increased the risk of ROP requiring treatment by 2.8-fold and AGTR1 by 4-fold, while the combined effect of both increased the risk 17.5-fold (95% CI 3.0–102.6; P = 0.0008). This evidence concerns the gene AGTR1 and retinopathy of prematurity.